SEI INVESTMENTS CO - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$11,692,719
+12.1%
130,528
+6.5%
0.02%
+16.7%
Q2 2023$10,432,496
+9.1%
122,530
+6.1%
0.02%0.0%
Q1 2023$9,560,091
+7.4%
115,532
+2.1%
0.02%
-10.0%
Q4 2022$8,903,326
+17.5%
113,200
+10.6%
0.02%
+17.6%
Q3 2022$7,577,000
+16.0%
102,345
+2.4%
0.02%
+21.4%
Q2 2022$6,533,000
+26.2%
99,921
+22.5%
0.01%
+40.0%
Q1 2022$5,178,000
+22.8%
81,556
+2.4%
0.01%
+25.0%
Q4 2021$4,218,000
-24.2%
79,677
+0.9%
0.01%
-33.3%
Q3 2021$5,566,000
+9.6%
78,957
+3.4%
0.01%
+9.1%
Q2 2021$5,078,000
-19.8%
76,370
+34.5%
0.01%
-31.2%
Q1 2021$6,330,000
-5.6%
56,781
+0.4%
0.02%
-5.9%
Q4 2020$6,709,000
+23.6%
56,541
-9.1%
0.02%
+6.2%
Q3 2020$5,428,000
-78.1%
62,212
-77.6%
0.02%
-79.2%
Q2 2020$24,828,000
+27.5%
277,180
+41.9%
0.08%
+6.9%
Q1 2020$19,474,000
-12.2%
195,335
+1.2%
0.07%
+9.1%
Q4 2019$22,185,000
-10.7%
193,076
-1.9%
0.07%
+3.1%
Q3 2019$24,833,000
-7.6%
196,857
-11.8%
0.06%
-27.3%
Q2 2019$26,867,000
+81.3%
223,274
+31.8%
0.09%
+76.0%
Q1 2019$14,819,000
-0.5%
169,349
+28.1%
0.05%
-5.7%
Q4 2018$14,896,000
+13.5%
132,243
+15.5%
0.05%
+10.4%
Q3 2018$13,121,000
+11.0%
114,513
-13.1%
0.05%
+20.0%
Q2 2018$11,824,000
+1094.3%
131,850
+873.4%
0.04%
+900.0%
Q1 2018$990,000
+63.4%
13,545
+29.7%
0.00%
+100.0%
Q4 2017$606,000
+409.2%
10,442
+293.1%
0.00%
Q3 2017$119,000
+54.5%
2,656
+35.7%
0.00%
Q2 2017$77,000
+6.9%
1,957
+10.6%
0.00%
Q1 2017$72,000
-84.4%
1,769
-84.6%
0.00%
-100.0%
Q4 2016$462,000
+1026.8%
11,489
+917.6%
0.00%
Q3 2016$41,000
-47.4%
1,129
-58.2%
0.00%
Q2 2016$78,000
-40.9%
2,701
-28.7%
0.00%
-100.0%
Q1 2016$132,000
-97.3%
3,789
-97.5%
0.00%
-96.7%
Q4 2015$4,968,000
-18.8%
154,085
-18.6%
0.03%
-46.4%
Q3 2015$6,121,000
-17.5%
189,390
+5.5%
0.06%
-16.4%
Q2 2015$7,423,000
-7.6%
179,469
+0.3%
0.07%
-4.3%
Q1 2015$8,035,000
+39.4%
178,863
+16.1%
0.07%
+37.3%
Q4 2014$5,765,000154,0690.05%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders